The US-based biotech start-up Anellotech recently announced significant progress in its Bio-TCat technology development program and has begun planning for scale-up design and engineering of a commercial plant with its process development and design partner IFPEN and commercialization, engineering, and licensing partner Axens.… Login to continue

Login or sign up